SCHULER JACK W - 21 May 2024 Form 4 Insider Report for BIODESIX INC (BDSX)

Role: Director, 10%+ Owner
Signature: /s/ Robin H. Cowie as Attorney-in-Fact for Jack Schuler
Issuer symbol: BDSX
Transactions as of: 21 May 2024
Net transactions value: $0
Form type: 4
Filing time: 23 May 2024, 19:14:54 UTC
Previous filing: 22 May 2024
Next filing: 30 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BDSX	Common Stock	Options Exercise		+86,960	+0.28%		30,794,682	23 May 2024	By Jack W. Schuler Living Trust	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BDSX	Restricted Stock Units	Award	$0	+46,686		$0.000000	46,686	21 May 2024	Common Stock	46,686		Direct	F3, F4, F5
transaction	BDSX	Stock Options (Right to Buy)	Award	$0	+37,050		$0.000000	37,050	21 May 2024	Common Stock	37,050	$1.57	Direct	F6
transaction	BDSX	Series A Non-Voting Convertible Preferred Stock	Options Exercise	$0	-2,174	-100%	$0.000000^*	0	23 May 2024	Common Stock	86,960		By Jack W. Schuler Living Trust	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Issuer's stockholders approved the conversion of shares of the Issuer's Series A Non-Voting Convertible Preferred Stock ("Preferred Stock") into shares of the Issuer's common stock ("Common Stock") at its 2024 annual meeting of stockholders held on May 21, 2024, after which each share of Preferred Stock automatically converted into 40 shares of Common Stock on May 23, 2024.
F2	Jack W. Schuler is the sole trustee of the Jack W. Schuler Living Trust.
F3	Each restricted stock unit (the "RSU") represents a contingent right to receive one share of Common Stock.
F4	These RSUs will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date. In the event the Reporting Person's continued service on the Board terminates other than for cause, these RSUs will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.
F5	Represents deferred RSUs. The shares of Common Stock underlying these RSUs will be issued to the Reporting Person following the Reporting Person's separation from service with the Issuer.
F6	This option will vest in full on March 31, 2025, generally subject to the Reporting Person's continued service with the Issuer. In the event the Reporting Person's continued service on the Board terminates other than for cause, this option will vest on a prorated basis based on the number of full months of service the Reporting Person completed during the applicable vesting period.